Log In
BCIQ
Print this Print this
 

Mesomark

  Manage Alerts
Collapse Summary General Information
Company Fujirebio Inc.
DescriptionELISA that detects soluble mesothelin-related peptides (SMRP) in the blood
Molecular Target Not applicable
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDaignose epithelioid or biphasic mesothelioma; Diagnose mesothelioma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today